Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Survival Benefit Seen With Radiation Therapy in Early Pancreatic Cancer
Link ID 3045
Title Survival Benefit Seen With Radiation Therapy in Early Pancreatic Cancer
Url http://www.medscape.com/viewarticle/569786?src=rss
Description Adjuvant external-beam radiation therapy (EBRT) improves survival in patients with operable, lymph node-negative pancreatic cancer, according to a report in the January 1st issue of Cancer. Reuters Health Information
Category Articles > Hematology-Oncology
Keywords
Date Feb 7, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Cell Phones May Be Linked to Increase in Tumors, But Evidence Still Inconclusive
  A meta-analysis found some evidence linking the use of cell phones to an increased risk for tumors, especially among long-term users. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. The Promise of Biomarkers for Bevacizumab
  Dr. Maurie Markman reviews a retrospective study identifying potential biomarkers for bevacizumab activity in patients with metastatic breast cancer. Medscape Genomic Medicine
Category:   Articles > Hematology-Oncology


3. Think About Surgery for High-Risk Prostate Cancer, Concludes Study
  A retrospective study shows that disease-specific survival is comparable between patients who undergo surgery and those who receive radiation plus hormone therapy. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. The Role of Body Image in Adjustment to Breast Cancer
  A finding that shame increases over time suggests that we have a long way to go in assisting breast cancer survivors with their changing body image. Medscape Nurses
Category:   Articles > Hematology-Oncology


5. Fewer Side Effects With Pemetrexed in Patients With NSCLC
  Pemetrexed is safe and well tolerated and makes cisplatin a more useful drug for patients with NSCLC. Dr. Mark Kris discusses the advantages of this combination regimen. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS